Key result
Thiol inhibitors at low concentrations inhibit the acto-H-meromyosin-forming ability of F-actin at low ionic strength, distinguishing enzymic active centers from interaction centers.
This basic science study demonstrates that thiol reagents inhibit the interaction between F-actin and heavy meromyosin at low ionic strength, distinguishing the active centers for enzymatic activity from those for complex formation.
Answers are grounded in this paper and cite their sources.
Distinguishes enzymatic from interaction sites in vitro; leaves open relevance to cardiac acto-myosin regulation.
It is now well known that actin and myosin possess thiol groups of functional significance. In the original investigations (Bailey & Perry, 1947) the actomyosin-formning and ATPase* activities of myosin were shown to be inhibited by thiol reagents, but it appeared that the ability of F-actin to form actomyosin under similar conditions was much less sensitive to these inhibitors. Kuschinsky & Turba (1951) confirmed the latter finding, but also established that if G-actin were treated with the thiol reagent Salyrgan it would no longer be polymerized to F-actin. The present investigation is concerned with the effects of thiol reagents on the interaction of F-actin with heavy meromyosin (H-meromyosin) under conditions of low ionic strength which are more comparable with those occurring in vivo. As the complex formed is soluble under these conditions the interaction can be studied viscometrically without the complicating effects of the relatively high ionic strength required to keep actomyosin in solution. The findings presented below indicate that at low ionic strength the acto-H-meromyosin-forming ability of F-actin is sensitive to low concentrations of certain thiol reagents. Evidence is also provided that suggests that the active centres of H-meromyosin involved in enzymic activity can be distinguished from those involved in the interaction with F-actin, which is responsible for the formation of the viscous complex. Certain aspects of this work have already been briefly reported (Perry & Leadbeater, 1962; Perry & Cotterill, 1963).
No takes yet. Share an insight, caveat, or question.
Perry et al. (1964) studied this question. Thiol inhibitors was evaluated on acto-H-meromyosin-forming ability of F-actin and enzymic activity. Thiol inhibitors at low concentrations inhibit the acto-H-meromyosin-forming ability of F-actin at low ionic strength, distinguishing enzymic active centers from interaction centers.
Synapse has enriched 10 related papers. Consider them for comparative context: